North America Bioimplants Market Size, Share & Trends Analysis Report By End User, By Type (Orthopedic Bioimplants, Cardiovascular Bioimplants, Spinal Bioimplants, Dental Bioimplants, Ophthalmology Bioimplants, and Others), By Country and Growth Forecast,

North America Bioimplants Market Size, Share & Trends Analysis Report By End User, By Type (Orthopedic Bioimplants, Cardiovascular Bioimplants, Spinal Bioimplants, Dental Bioimplants, Ophthalmology Bioimplants, and Others), By Country and Growth Forecast, 2024 - 2031


The North America Bioimplants Market would witness market growth of 7.4% CAGR during the forecast period (2024-2031).

The US market dominated the North America Bioimplants Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $59,597.4 million by 2031. The Canada market is experiencing a CAGR of 9.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 8.8% during (2024 - 2031).

The market has experienced substantial growth as a result of technological advancements. Biotechnology, materials science, and medical engineering innovations have developed more effective, durable, and biocompatible implants. Biotechnology, for instance, has enabled the manipulation of biological systems to create materials and structures highly compatible with human tissues.

The aging population is another critical factor driving the demand for these implants. As people live longer, the prevalence of age-related conditions such as osteoarthritis, cardiovascular diseases, and dental problems increases. These conditions often necessitate the use of these implants for effective treatment and management. In addition to specific medical conditions, the overall increase in life expectancy contributes to the demand for these implants.

The growing medical tourism industry is a key factor driving the demand for these implants in cosmetic and reconstructive surgery in Mexico. Patients from the United States, Canada, and other countries are attracted to Mexico for its high-quality medical care at a fraction of the cost in their home countries. According to the Mexican Association of Plastic, Aesthetic, and Reconstructive Surgery (AMCPER), there is a significant increase in the number of cosmetic surgeries performed annually, with breast augmentation and rhinoplasty being the most popular procedures. For patients who are interested in aesthetic enhancements, Mexico is a preferred destination due to the affordability and accessibility of these implants. Hence, the increasing acceptance of cosmetic and reconstructive surgery across various nations in North America is significantly boosting the demand for these implants.

Based on End User, the market is segmented into Hospitals, Speciality Clinics, and Ambulatory Surgical Centers. Based on Type, the market is segmented into Orthopedic Bioimplants, Cardiovascular Bioimplants, Spinal Bioimplants, Dental Bioimplants, Ophthalmology Bioimplants, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Stryker Corporation
  • Arthrex, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Medtronic PLC
  • Smith & Nephew PLC
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Victrex plc
North America Bioimplants Market Report Segmentation

By End User
  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centers
By Type
  • Orthopedic Bioimplants
  • Cardiovascular Bioimplants
  • Spinal Bioimplants
  • Dental Bioimplants
  • Ophthalmology Bioimplants
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Bioimplants Market, by End User
1.4.2 North America Bioimplants Market, by Type
1.4.3 North America Bioimplants Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Bioimplants Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Speciality Clinics Market by Country
4.3 North America Ambulatory Surgical Centers Market by Country
Chapter 5. North America Bioimplants Market by Type
5.1 North America Orthopedic Bioimplants Market by Country
5.2 North America Cardiovascular Bioimplants Market by Country
5.3 North America Spinal Bioimplants Market by Country
5.4 North America Dental Bioimplants Market by Country
5.5 North America Ophthalmology Bioimplants Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Bioimplants Market by Country
6.1 US Bioimplants Market
6.1.1 US Bioimplants Market by End User
6.1.2 US Bioimplants Market by Type
6.2 Canada Bioimplants Market
6.2.1 Canada Bioimplants Market by End User
6.2.2 Canada Bioimplants Market by Type
6.3 Mexico Bioimplants Market
6.3.1 Mexico Bioimplants Market by End User
6.3.2 Mexico Bioimplants Market by Type
6.4 Rest of North America Bioimplants Market
6.4.1 Rest of North America Bioimplants Market by End User
6.4.2 Rest of North America Bioimplants Market by Type
Chapter 7. Company Profiles
7.1 Stryker Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Arthrex, Inc.
7.2.1 Company Overview
7.2.2 SWOT Analysis
7.3 Zimmer Biomet Holdings, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Smith & Nephew PLC
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional and Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Dentsply Sirona, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental & Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Boston Scientific Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 SWOT Analysis
7.9 Abbott Laboratories
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Victrex plc
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings